Logo
    Search

    Brain Scientists Are Tripping Out Over Psychedelics

    en-usDecember 21, 2022

    Podcast Summary

    • Exploring Psychedelic Drugs for Mental Health TreatmentPsychedelic drugs like MDMA, psilocybin, LSD, offer potential in treating anxiety, depression, PTSD, substance abuse, and OCD, and provide insights into learning and consciousness.

      Psychedelic drugs, such as MDMA, psilocybin, LSD, and others, are gaining increasing attention from brain scientists for their potential in treating various psychiatric disorders, including anxiety, depression, PTSD, substance abuse, and obsessive compulsive disorder. These drugs also offer insights into learning and consciousness. While research in this area has been on the fringe in the past, recent scientific meetings, like the Society For Neuroscience, have seen a surge in interest and studies. For instance, Emma Hules from the University of Michigan shared her research at a local bar during the conference. Overall, psychedelic drugs may provide a new way to understand and address mental health issues.

    • Revival of interest in psychedelics for therapeutic benefitsPsychedelic drugs like psilocybin are gaining renewed interest for their potential therapeutic uses, particularly in treating mental health issues and chronic pain, based on recent studies.

      Psychedelic drugs, such as psilocybin, are once again gaining the interest of brain scientists due to their potential therapeutic benefits. After a hiatus in research following the negative connotations and legal issues in the 1960s, scientists have been re-exploring the use of these drugs for treating conditions like chronic pain and mental health issues, such as depression and anxiety. Two significant studies in 2016 showed that psilocybin reduced depression and anxiety in cancer patients. The renewed interest in psychedelics has been fueled by the growing body of research suggesting their potential therapeutic benefits, making it an exciting area of neuroscience. However, it's important to note that while the research is promising, more studies are needed to fully understand the potential risks and benefits of these drugs.

    • Neuroscience community shows growing interest in psychedelics and neuroplasticityResearch suggests psychedelics may enhance brain plasticity, leading to potential therapeutic applications for disorders like depression and PTSD.

      Key takeaway from the neuroscience meetings I attended was the overwhelming interest in the field of psychedelics and their impact on neuroplasticity. With over a thousand people attending a session, it was clear that this area of research is gaining significant attention. Brain scientist Alex Kwan from Cornell University shared his research on how psilocybin, a psychedelic compound, alters the structure of brain plasticity in mice by enhancing the connections between neurons. This ability to create stronger and more numerous connections is crucial to the brain's adaptability. Our brains naturally have the capacity to learn and change, but psychedelics may enhance this plasticity, making it more effective. This increased flexibility is believed to be the reason why researchers are exploring the potential of psychedelics as a treatment for disorders such as depression and PTSD. Essentially, these are promising findings that suggest psychedelics may help our brains adapt and learn more effectively, which could lead to new therapeutic applications.

    • Psychedelic drugs may rewire the brain for long-term mental health improvementsA single dose of psychedelic drugs can lead to significant improvements in major depression, suggesting long-term changes in brain function, contrasting the need for daily use of psychiatric medications.

      Psychedelic drugs may have a long-lasting impact on mental health conditions by rewiring the brain. Neurologist Dr. Giede Knutsen from the University of Copenhagen in Denmark has observed that a single dose of these drugs can lead to significant improvements in major depression, suggesting long-term changes in brain function. This is in contrast to current psychiatric medications that require daily use. However, it's important to note that psychedelic treatments come with risks, such as hallucinations and symptoms similar to schizophrenia. Therefore, careful preparation and provider support are crucial during the experience to ensure safety and effectiveness. Despite the promising findings, it's essential to approach these drugs with caution and acknowledge their potential risks.

    • Incremental improvement with psychedelicsPsychedelics like LSD and psilocybin show promise in clinical trials for mental health conditions but are not likely to be transformative solutions, rather an incremental improvement

      Psychedelics, such as LSD and psilocybin, are showing promise in clinical trials for treating various mental health conditions. However, it's important to note that these studies are conducted in controlled environments with clinicians present. The hype surrounding psychedelics comes from both investors looking to enter the drug business and advocates for legalization. While these drugs may offer important improvements, they are not likely to be the transformative solutions some had hoped for. Instead, they are expected to help individuals who haven't responded to other treatments. As the National Institute of Mental Health Director, Dr. Joshua Gordon, puts it, psychedelics will probably represent an incremental improvement rather than a revolutionary change.

    • Flexible learning and convenient catering solutionsOnline food ordering and 24/7 support simplify catering for businesses, while Capella University's FlexPath program offers flexible education pace

      Flexible learning and convenient catering solutions can significantly enhance personal and professional growth. During this episode of Shortwave from NPR, listeners were introduced to Easycater, a company dedicated to simplifying the process of ordering food for meetings and events with online ordering and 24/7 live support. Capella University was also highlighted as a sponsor, offering a flexible learning format called FlexPath that allows students to earn their degrees at their own pace. These resources provide valuable solutions for businesses and individuals seeking to streamline their operations and focus on their goals. Whether it's furthering your education or providing nourishment for your team, these flexible and supportive options are essential for success in today's fast-paced world. To learn more about Easycater, visit easycater.com, and for more information on Capella University and its FlexPath program, check out capella.edu.

    Recent Episodes from Short Wave

    Want Juicy Barbecue This Fourth Of July? Cook Low And Slow

    Want Juicy Barbecue This Fourth Of July? Cook Low And Slow
    Perfecting your grilling technique ahead of the Fourth of July? Chefs will tell you that cooking is not just an art — it's a science. And the spirit of summer barbecues, NPR science correspondent Sydney Lupkin brings us this encore piece about how understanding the chemistry of cooking meat can help you perfect your barbeque. It's all about low and slow cooking.

    This story was originally reported for NPR by Gisele Grayson. Read her reporting.

    Curious about other science powering the things you love? Email us at shortwave@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJuly 01, 2024

    Move Over Norse Mythology, There's A New Loki In Town — A Dinosaur

    Move Over Norse Mythology, There's A New Loki In Town — A Dinosaur
    A brand new species of ceratops, or horned dinosaur, was recently discovered in northern Montana. The dinosaur is called Lokiceratops rangiformis, after the Norse god Loki, and is believed to have lived roughly eighty million years ago. The bones of the plant-eating dinosaur were found on private land in an area well known for its large amount of fossils, and at first, researchers thought the bones belonged to another species of dinosaur!

    Want to hear more about dinosaurs or other paleontological discoveries? Email us at shortwave@npr.org to let us know. We'd love to hear from you!

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 28, 2024

    The Human Brain Is Hardwired To Recognize Faces. But What If You Can't?

    The Human Brain Is Hardwired To Recognize Faces. But What If You Can't?
    Humans are hardwired to see faces — even in inanimate objects. We have a lima bean-shaped part of our brains dedicated to facial recognition. But this process isn't always straightforward. Science journalist Sadie Dingfelder is one of 10 million Americans who are face blind, or struggle to recognize the faces of people they know. In her new book, Do I Know You? she dives into this, as well as the science of memory and imagination.

    Want more episodes on the wonder of the human brain? Email us at shortwave@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 26, 2024

    Some Stars Explode As They Die. We Look At Their Life Cycle

    Some Stars Explode As They Die. We Look At Their Life Cycle
    This summer, scientists have their eyes and telescopes trained on the small constellation system T Coronae Borealis. They think it will explode as part of a periodic nova — a once-in-a-lifetime event according to NASA scientists. And so, with the help of astrophysicist Sarafina El-Badry Nance, we continue our journey farther and deeper into spacetime with a look at the stars: How they're born and how they die. Sarafina has always been drawn to one particular star: Betelgeuse, a red supergiant in the shoulder of the constellation Orion that is nearing the end of its life. What stages of life did Betelgeuse — or any star — go through before it reached this moment?

    This episode is part of our series Space Camp — all abut the weird, wonderful phenomena in our universe. Check it out here: https://npr.org/spacecamp

    Curious about the night sky? Email us at shortwave@npr.org — we'd love to hear from you!

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 25, 2024

    Earth Is More Than A Planet With Life On It. It's A "Living Planet"

    Earth Is More Than A Planet With Life On It. It's A "Living Planet"
    About ten years ago, science writer Ferris Jabr started contemplating Earth as a living planet rather than a planet with life on it. It began when he learned that the Amazon rainforest doesn't simply receive the rain that defines it; rather, it helps generate that rain. The Amazon does that by launching bits of biological confetti into the atmosphere that, in turn, seed clouds. After learning this, he began looking for other ways life changes its environment. That led to his new book Becoming Earth: How Our Planet Came to Life. He talks to host Regina G. Barber about examples of life transforming the planet — from changing the color of the sky to altering the weather.

    Have a story about the environment you'd like us to cover? Email us at shortwave@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 24, 2024

    We're In For A Brutal Hurricane Season, According To Predictions

    We're In For A Brutal Hurricane Season, According To Predictions
    The National Oceanic and Atmospheric Administration is predicting a record number of hurricanes this season, which began on June 1 and runs through Nov. They're forecasting anywhere from 17 to 25 storms in the Atlantic basin, including at least four major hurricanes. Scientists think this storm activity could be due to strong winds, warmer ocean temperatures and a scientific mystery unfolding in the Atlantic.

    Questions about hurricanes or other weather disasters? Email us at shortwave@npr.org — we'd love to consider it for a future episode!

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 21, 2024

    What 'Inside Out 2' Got Right About Anxiety, Per A Psychologist

    What 'Inside Out 2' Got Right About Anxiety, Per A Psychologist
    Pixar's new movie, Inside Out 2 came out Friday. It's the sequel to the 2015 movie Inside Out, which follows the life of 11-year-old Riley and her family as they move to San Francisco. In Inside Out 2, Riley is 13 and thriving in her new city. She has friends and is a star on her hockey team. But when puberty hits one night, four new emotions come into play: Envy, Ennui, Embarrassment and most of all, Anxiety.

    Clinical psychologist and Inside Out 2 consultant Lisa Damour says the movie is surprisingly accurate when it comes to experiencing anxiety and puberty. Plus, she offers some guidance to help make the most of our anxiety.

    Have other pop culture science you want us to decode? Email us at shortwave@npr.org — we'd love to consider it for a future episode!

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 19, 2024

    Pluto Isn't A Planet — But It Gives Us Clues For How The Solar System Formed

    Pluto Isn't A Planet — But It Gives Us Clues For How The Solar System Formed
    Pluto hasn't been a planet for almost 20 years. In the early 2000s, scientists discovered several objects of a similar size to Pluto. So, during the summer of 2006, members of the International Astronomical Union convened in Prague to reconsider what counts as a planet in our solar system. IAU members decided that there were three criteria to be a planet — and Pluto did meet all of them.

    But planetary scientist Wladymir Lyra says that even though it was downgraded to a dwarf planet, Pluto still has much to teach us about planet formation. This episode, he also lays out his case for Pluto — and many other objects in the solar system — to be considered a planet.

    This episode is part of Short Wave's space camp series about all the weird, wonderful things happening in the universe. Check out the full series.

    Questions about the state of our universe or smaller happenings here on planet Earth? Email us at shortwave@npr.org — we'd love to consider it for a future episode!

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 18, 2024

    Inheriting: Leah & Japanese American Incarceration

    Inheriting: Leah & Japanese American Incarceration
    Hey, Short Wavers! Today, we're sharing a portion of Inheriting, an 8-part limited series hosted by Emily Kwong about Asian American and Pacific Islander family history. In this excerpt, we follow the story of Leah Bash.

    Leah is an avid runner, a dog mom, a wife – and there's a part of her family's history she can't stop thinking about. Both sides of her family were incarcerated during WWII, alongside 125,000 other Japanese Americans. After Leah learns about her father's struggles with panic attacks and is herself diagnosed with bipolar disorder, she starts to wonder: Could those experiences at camp have far-reaching consequences decades later?

    Listen to Inheriting and check out the show's resource guide for more information on getting personal with the past.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy
    Short Wave
    en-usJune 15, 2024

    Related Episodes

    #113 Ketamine and Psychedelics in Medicine with Dr. Boris Heifetz

    #113 Ketamine and Psychedelics in Medicine with Dr. Boris Heifetz

    In this episode of Hart2Heart, host Dr. Mike Hart talks with Dr. Boris Heifetz, an assistant professor of anesthesiology at Stanford. Dr. Heifetz shares insights from his extensive research and clinical experience, touching on topics like the placebo effect, the interplay between drugs and patient psychology, and the future of psychedelic medicine.

    Show Notes:

    • [0:00] Welcome back to the Hart2Heart Podcast with Dr. Mike Hart. Dr. Hart introduces the guest, Dr. Boris Heifetz to the listeners   

    • [0:30] Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients

    • [4:15] The debate of drug vs. ‘trip’ in psychedelic therapy

    • [7:45] “The short answer is, I think you can achieve psychological transformation without dissociation.”

    • [10:00] Ketamine for suicidal ideations

    • [18:00] The concept of dream awakening and its impact on trauma

    • [20:00] Discussing the scalability and accessibility of psychedelic therapy

    • [22:00] Importance of aftercare in psychedelic treatments 

    • [30:00] Ketamine and opioid-like effects discussed 

    • [31:45] Painkiller 

    • [37:00] Dr. Boris Heifetz reiterates the idea of an inner healing intelligence

    • [42:00] The interplay between SSRIs and psychedelics

    • [52:00] Question: Do you feel ketamine falls into the care of family physicians? Or do you feel like that should be delegated more to anesthetists and psychiatrists?

    • [53:30] If you want to know more about Dr. Boris Heifetz check him out on X @TheBorisLab or at https://heifetslab.stanford.edu/

    ---

    Dr. Mike Hart is a Cannabis Physician and Lifestyle Strategist. In April 2014, Dr. Hart became the first physician in London, Ontario to open a cannabis clinic. While Dr. Hart continues to treat patients at his clinic, his primary focus has shifted to correcting the medical cannabis educational gap which exists in the medical community. 

    Connect on social with Dr. Mike Hart:

    Social Links:

    Screening: The Next Generation

    Screening: The Next Generation

    Cancer screening has saved countless lives through the early detection of breast, cervical, colorectal, and lung cancer. But there are still so many forms of cancer that slip through the cracks. Now, developments in medical research — such as multi-cancer screening blood tests and genomic tests — are promising to revolutionize cancer diagnostics.

    In this episode, we talk to experts about the medical tech that is reshaping the field of early detection. Dr. Joseph Mikhael, Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute, talks about the importance of multi-cancer early detection tests and genomics in detecting cancers that we don't currently screen for. Dr. Brian Druker, Director of the Knight Cancer Institute at Oregon Health & Science University, talks about his role in spearheading the field of precision-based early cancer detection. And Jody Hoyos, President and Chief Operating Officer of Prevent Cancer Foundation, advocates for the passage of the Medicare Multi-Cancer Early Detection Screening Coverage Act to ensure equitable access to life-saving biotech.

    The Big Screen is a product of OffScripHealth.

    To learn more about rescheduling your cancer screening appointments, visit https://www.preventcancer.org/back-on-the-books/.

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    The Alumni Association

    The Alumni Association

    By the 1980s, cancer was no longer a death sentence. But the question of what surviving actually meant was unanswered. Cancer survivors had to navigate issues around employment, relationships, and the emotional and physical side effects of treatment in a world that largely didn’t know what to do with them. (and they were still called “victims.”) In 1985, a young doctor named Fitzhugh Mullan wrote an essay called “Seasons of Survival” about his own experience with cancer. His piece helped popularize the term “cancer survivor” and resonated with a growing number of survivors, who were starting to form support groups around the country. Among them was Catherine Logan Carrillo, the founder of People Living Through Cancer in New Mexico, who asked Fitzhugh to help her convene an “alumni association” for cancer survivors. And they did, during one monumental weekend in Albuquerque. For more information about this series, visit https://CancerMavericks.com

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    Protecting the Peace in Psychedelics: An Interview with Ashley Carmen

    Protecting the Peace in Psychedelics: An Interview with Ashley Carmen

    Ever wondered about the importance of ethical standards and professional licensure in the realm of therapy and psychedelic guidance?

    Imagine seeking therapy or guidance in the world of psychedelics and realizing that your chosen guide doesn't adhere to ethical standards or possess the necessary training. The potential risks and consequences could be significant.

    In today's episode, we delve into the critical aspects of therapy, the significance of being a licensed therapist, and the potential pitfalls in the emerging field of psychedelic therapy. Our guest, Ashley Carmen, a licensed psychotherapist with extensive experience in both traditional and psychedelic therapy, sheds light on the importance of ethical considerations, proper training, and the potential dangers of unregulated practices.

    In this episode, you’ll learn:

    👉 The rigorous journey to becoming a licensed therapist and the ethical considerations involved.

    👉 The potential risks and harm associated with unlicensed individuals offering psychedelic therapy.

    👉 The role of governing boards and ethical codes in ensuring the safety and well-being of therapy seekers.

    👉 The necessity of clear boundaries, documentation, and transparency in therapeutic relationships.

    👉 How consumers can be more discerning and ask critical questions when seeking therapy or psychedelic guidance.

    Join us as we navigate the complex landscape of therapy and psychedelics, aiming to empower listeners to make informed decisions and prioritize their well-being in these transformative journeys. Welcome to Tailored Talks – let's dive in!

     

    Connect with Ashley: 

    Instagram: @psychedelicguidenetwork

    Website: https://www.psychedelicguidenetwork.com/

     


    TOPICS DISCUSSED

    The importance of understanding therapy and the role of a licensed therapist.

    The extensive training and licensure process for therapists

    • The significance of maintaining ethical standards in therapy

    • Exploring the concepts of transference and countertransference

    • The potential dangers of untrained individuals claiming to be therapists

    • Addressing the issue of retraumatization in therapeutic relationships

    • Insights into the licensing boards and the grievance process for therapists

    • Documentation and ethical considerations.

    • The challenges and responsibilities of maintaining therapeutic boundaries

    • The lack of regulation in the psychedelic space and the importance of informed choices in seeking therapeutic support

    • Understanding the role of organizations like MAPS (Multidisciplinary Association for Psychedelic Studies) in training therapists

    • The need for seekers to ask relevant questions and understand the background and training of individuals offering psychedelic therapy